Purchase Order HHSN268201500020A
Award Date 12/8/14
Potential Completion Date 12/17/19
Potential Value $302K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on July 10, 2012, for $24,570.00 to provide a maintenance agreement for a BD FACSAria II flow cytometer. Performance takes place in Bethesda, Maryland. The contract carries a firm fixed price and ultimate completion date of August 29, 2013. The FACSAria II is a complex flow cytometer sorter with specialized fluidics and unique electronic circuit boards requiring ongoing...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $38,127.60 on August 30, 2019, for BD Biosciences FACSAria maintenance agreement services, with ultimate completion on August 29, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no small business set-aside.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) on March 15, 2022, for BD FACSAria II flow cytometer sorter maintenance services, with a ceiling value of $38,718.00 and an ultimate completion date of March 14, 2023. Work is performed in San Jose, California. The procurement was issued on full and open competition with no small business set-aside.</p>
- The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences division) for $29,376.00 on February 10, 2015, with an ultimate completion date of March 14, 2016. The order covers a FACSARIA II special order system maintenance agreement, priced on a firm fixed price basis with no set-aside. Work is performed at Bethesda, Maryland. This is a commercial item procurement for flow cytometry system maintenance, consistent with BD Biosciences'...
- <p>The National Heart Lung and Blood Institute awarded a purchase order to BD Biosciences for $29,376.00 on February 27, 2014, for one year of maintenance on a FACSAria II flow cytometer located at the NHLBI Division of Intramural Research in Bethesda, Maryland. Work is scheduled for completion by March 14, 2015. This is a firm fixed-price commercial purchase with no set-aside used.</p>
- <p>The National Heart Lung and Blood Institute awarded a purchase order to Becton, Dickinson And Company (BD Biosciences) on March 15, 2020, for BD Biosciences Aria II Flow Cytometer maintenance services, with a ceiling value of $32,562.00 and firm fixed pricing. Performance occurs in Bethesda, Maryland, with an ultimate completion date of March 14, 2021. No set-aside applied to this acquisition.</p>
- <p>The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on December 10, 2009, with a ceiling value of $23,180.04 for service and maintenance of the FACSARIA 3 laser system, serial number P0186.</p> <p>The order runs from November 29, 2009, through November 28, 2010, and is priced on a firm-fixed-price basis. Place of performance is Bethesda, Maryland. The award was funded under ARRA.</p>
- The National Heart Lung and Blood Institute issued a delivery order to Becton, Dickinson And Company (BD Biosciences division) on September 22, 2009, with a ceiling value of $10,689.96 for maintenance of a BD FACSCalibur 4-Color flow cytometer (serial number E4876). The order covers preventive maintenance and parts for one year, from September 30, 2009 through September 29, 2010, including two preventive maintenance inspections and two PM kits, with quarterly payment in arrears. Place of...
- Becton, Dickinson and Company (BD), through its BDB Division operating as BD Biosciences, received a delivery order award from the National Heart, Lung, and Blood Institute (NHLBI) on April 1, 2024, for a Service Agreement covering a FACSAria III 5-laser flow cytometry system. This firm fixed-price delivery order, with a ceiling value of $102,132.36 and ultimate completion date of March 31, 2027, was issued without a set-aside designation and represents a task order against the Multiple Award...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) valued at $37,010.20 on May 7, 2024, for service maintenance of BD FACSAria Fusion flow cytometry equipment including OBI lasers. Place of performance is North Bethesda, Maryland. The order carries a firm fixed price and ultimate completion date of May 6, 2025.</p>